Virtual screening on SARS-CoV-2 Nsp14_testing of 5474 hits in a Nsp14 biochemical assay and an A549-hACE2 SARS-CoV-2 infected cells

Ellen Van Damme

doi:10.5281/zenodo.6669499

Published June 20, 2022 | Version 1.0.0

Dataset Open

Virtual screening on SARS-CoV-2 Nsp14_testing of 5474 hits in a Nsp14 biochemical assay and an A549-hACE2 SARS-CoV-2 infected cells

Ellen Van Damme¹

1. Janssen Pharmaceutica NV

This report describes the most relevant results of virtually screening the Janssen Pharmaceutica compound collection for potential activity against SARS-CoV-2 Nsp14 and confirmation of potential hits in a SARS-CoV-2 Nsp10/Nsp14 biochemical exonuclease assay and in a A549-hACE2 cell-based anti-SARS-CoV-2 assay.

Files

Files (224.7 kB)

Name	Size
Virtual screening on SARS-CoV-2 Nsp14_testing of 5474 hits in a Nsp14 biochemical assay and an A549-hACE2 SARS-CoV-2 infected c (1).xlsx md5:a1265941fb7d9984820699ea8587a477	224.7 kB	Download

528

Views

Downloads

Show more details

	All versions	This version
Views	528	528
Downloads	95	95
Data volume	21.6 MB	21.6 MB

More info on how stats are collected....

DOI

Resource type

Dataset

Publisher

Zenodo

Languages

English

License: Creative Commons Attribution 4.0 International

The Creative Commons Attribution license allows re-distribution and re-use of a licensed work on the condition that the creator is appropriately credited. Read more

Technical metadata

Created: June 20, 2022
Modified: June 22, 2022

Virtual screening on SARS-CoV-2 Nsp14_testing of 5474 hits in a Nsp14 biochemical assay and an A549-hACE2 SARS-CoV-2 infected cells

Authors/Creators

Description

Files

Files (224.7 kB)